pharmacy laws of north carolina - North Carolina Board of ...

www.ncbop.org › LawsRules › Statutes

2 days ago - This compilation of some of the Pharmacy Laws of North Carolina is provided ...... other than a pharmacist to dispense or compound any prescription drug unless ...

Mississippi pain cream fraud: Pharmacist sentenced to 10 years, must repay $243.5 million

https://www.hattiesburgamerican.com/story/news/crime/2019/10/31/ridgeland-pharmacist-sentenced-10-years-pain-cream-fraud/4059338002/

Drug rep involved in scheme ordered to pay $10 million in restitution

https://www.bizjournals.com/buffalo/news/2019/10/30/drug-rep-involved-in-scheme-ordered-to-pay-10.html

FDA Panel Votes 9-7 to Yank Makena Approval No members thought the current data supported a benefit for preterm birth prevention by Molly Walker, Associate Editor, MedPage Today October 29, 2019

https://www.medpagetoday.com/obgyn/pregnancy/83021

New Study Illustrates the Limitations of Compounded Thyroid Hormones: Drugs Extemporaneously Created by Pharmacies May Not Offer Consistent Potency PR Newswire PR NewswireOctober 31, 2019

https://finance.yahoo.com/news/study-illustrates-limitations-compounded-thyroid-150100261.html

Pharmacy owner gets 10 years for $243M health care fraud that ripped off veterans’ program involving compounded drugs

https://finance.yahoo.com/news/pharmacy-owner-gets-10-years-104433048.html

Compounding Pharmacies Are an Unchecked Threat to Americans’ Health BY LISA DWYER October 25, 2019

Compounding Pharmacies Are an U - King & Spalding

https://www.kslaw.com › attachments › original › Compounding_Pharmaci...

7 days ago - Oliver's audience was rightly shocked to learn that compounding pharmacies, companies that purportedly create customized prescription medications, face an ...

Pharmacy owner sentenced in state's largest health care fraud ...

https://newsms.fm › pharmacy-owner-sentenced-in-states-largest-health-car...

13 hours ago - During this time, Spell and other co-conspirators marketed compounded medications at his pharmacies. Rather than formulating compounded medications ...

Statement from Janet Woodcock, M.D., director of FDA’s Center for Drug Evaluation and Research on new testing results, including low levels of impurities in ranitidine drugs

Americans deserve to have confidence in the quality of drugs the U.S. Food and Drug Administration regulates – from the prescription medicines they take to the over-the-counter (OTC) products they use in their daily lives. Helping assure the quality and safety of these products is one of our greatest responsibilities. Over the past several weeks, the FDA has been investigating the detection of a contaminant known as N-Nitrosodimethylamine (NDMA) in ranitidine medications, commonly known by the brand name Zantac. We set out to fully understand this issue and provide actionable information for Americans who use these medications. The information we’ve gathered as part of our ongoing ranitidine investigation has been vital to answering the questions we’ve received about the potential risk of these products. Throughout this process, we’ve been updating our...

Read More

Texas Board of Pharmacy Meeting Scheduled for November 5, 2019

Details of the upcoming meeting are as follows:

Date: November 5, 2019

Time: 9:00 a.m. – Conclusion

Location: William P. Hobby, Jr. Building, 333 Guadalupe Street, Suite 2-225, Austin, Texas 78701

Materials: Posted here when available